Toshiyuki Onogawa

Title: Innovations of Toshiyuki Onogawa

Introduction

Toshiyuki Onogawa is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of three patents to his name, Onogawa's work has the potential to impact medical treatments significantly.

Latest Patents

Onogawa's latest patents include a benzodiazepine compound and pharmaceutical composition. This invention provides a novel benzodiazepine compound that blocks the Icurrent or the Kv1.5 channel potently and more selectively than other Kchannels. The benzodiazepine compound is represented by General Formula (1), wherein R, R, R, and R are each independently hydrogen or lower alkyl. Additionally, R and R may be linked to form lower alkylene, while R and R are each independently hydrogen or an organic group.

Career Highlights

Toshiyuki Onogawa is currently associated with Otsuka Pharmaceutical Company, Limited. His work at this esteemed organization has allowed him to focus on innovative pharmaceutical solutions. His contributions have been recognized within the industry, showcasing his expertise and dedication to advancing medical science.

Collaborations

Onogawa has collaborated with notable colleagues, including Kenji Tsujimae and Kunio Oshima. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Toshiyuki Onogawa's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the development of benzodiazepine compounds, highlight the importance of research and collaboration in advancing medical treatments.